BioSpace News Archive

Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported recent business progress and financial results for the first quarter ended March 31, 2024.

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 and will provide a business update.

DENTSPLY SIRONA Inc. announced its financial results for the first quarter of 2024.

Global health company The Cigna Group reported strong first quarter 2024 results reflecting growth across its diversified portfolio of businesses.

SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, reported first quarter financial results for the period ended March 31, 2024 and provided an update on recent company developments.

Aanastra, Inc. announced multiple presentations at the 2024 American Society for Gene and Cell Therapies, taking place May 7-11, 2024, in Baltimore, MD.

Zomedica Corp. announced the issuance of three new patents, bolstering the intellectual property protection for its revolutionary TRUFORMA diagnostic platform.

BD, a leading global medical technology company, announced results for its second quarter of fiscal 2024, which ended March 31, 2024.

Drug Farm announced that the chronic hepatitis B patient data from their Phase 1b trial was accepted as a late breaking poster presentation at the 2024 European Association for the Study of the Liver conference that will be held in Milan, Italy between 05 June 2024 to 08 June 2024.

Krystal Biotech, Inc., a commercial-stage biotechnology company, announced that the Company will be presenting new preclinical data highlighting the potential of the Company’s HSV-1 based vector platform for back of the eye gene delivery at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting being held from May 5-9, 2024 in Seattle, Washington.